Stocks
Iovance Biotherapeutics (IOVA) Net margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -37 345% | -226.8% | -148.4% | -123.9% | ||||
| Changes by years, y/y, % | +37 119pp | +78pp | -93.7% | ||||||
Iovance Biotherapeutics. Net margin, %
Iovance Biotherapeutics. Net margin, changes, pp
Iovance Biotherapeutics (IOVA) Net margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| Net margin, % | ? | -186.2% | -135.3% | -82.9% | -110.7% | -47.6% | -123.9% | |
| Changes by years, y/y, % | +126pp | +7pp | +24pp | +125pp | +139pp | |||
| Changes by quarters, q/q, % | +49pp | +51pp | +52pp | -28pp | +63pp | |||
